Hera Therapeutics Inc.

New Filing
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Jul 10, 2014
Total Offering

$1,300,000

Amount Sold

$1,100,000

Investors

14

First Sale

Jun 24, 2014

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2012
Non-Accredited Investors
No

Related Persons

NameRole
Karl Y Hostetler
Related Person
Michael J Sullivan
Related Person
William L. Respess
Related Person
Michael D. Cannon
Related Person

Company

Antiva Biosciences, Inc.

14024 RUE SAINT RAPHAEL

DEL MAR, CA, 92014-3043

858.342.5556

SEC Filing

0001563355-14-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free